WallStreetZenWallStreetZen

NASDAQ: WINT
Windtree Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Windtree Therapeutics earnings were -$20.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest WINT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.0M, down 7,516.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, WINT reported annual earnings of -$5.5M, with -73% growth.

WINT earnings history

Current Revenue
$0.0
Current Earnings
-$20.7M
Current Profit Margin
0%

WINT Return on Equity

Current Company
-294.4%
Current Industry
-60.2%
Current Market
31.5%
WINT's Return on Equity (-294.4%)... subscribe to Premium to read more.
High Return on Equity Performance

WINT undefined

Current Company
-72.9%
Current Industry
-2.5%
WINT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when WINT announces earnings.

WINT undefined

Current Company
-78.51%
Current Industry
5.8%
WINT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

WINT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
WINT-$15.45M-$20.75MN/A-$933.98
PBM-$51.11M-$51.16MN/A-$4,674.33
ENTO-$9.97M-$25.18MN/A-$8.07
ALZN-$4.16M-$4.28MN/A-$27.36
PTIX-$5.19M-$5.24MN/A-$13.11
View Top Biotech Stocks

Windtree Therapeutics Earnings Reports & History FAQ

What were Windtree Therapeutics's earnings last quarter?

On WINT's earnings call on Invalid Date, Windtree Therapeutics (NASDAQ: WINT) reported Q1 2025 earnings per share (EPS) of -$4.63, up 100.42% year over year. Total WINT earnings for the quarter were -$5.04 million. In the same quarter last year, Windtree Therapeutics's earnings per share (EPS) was $1,099.37.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.

Is Windtree Therapeutics profitable or losing money?

As of the last Windtree Therapeutics earnings report, Windtree Therapeutics is currently losing money. Windtree Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$16.05 million, a 169.27% increase year over year.

What was WINT's earnings growth in the past year?

As of Windtree Therapeutics's earnings date in Invalid Date, Windtree Therapeutics's earnings has grown year over year. WINT earnings in the past year totalled -$20.75 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.